Related Experiment Video
Updated: Aug 8, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
3-Benzimidazol-2-yl-1H-indazoles as potent c-ABL inhibitors
Christopher M McBride1, Paul A Renhowe, Thomas G Gesner
1Small Molecule Drug Discovery, Medicinal Chemistry Department, Chiron Corporation, 4560 Horton Street, Emeryville, CA 94608, USA.
Abstract:
The 3-benzimidazol-2-yl-1H-indazole scaffold was developed as an alternate scaffold for our receptor tyrosine kinase (RTK) inhibitor program. In exploring the SAR of this series, it was discovered that a subset of these compounds potently inhibit the enzyme c-ABL. The SAR of these compounds is described.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Inhibition of Cdk Activity
Anthelminthic Agents
Inhibitors of Bacterial DNA Synthesis
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Antiprotozoal Agents
